ZA938116B - Transdermal delivery of ketorolac - Google Patents
Transdermal delivery of ketorolacInfo
- Publication number
- ZA938116B ZA938116B ZA938116A ZA938116A ZA938116B ZA 938116 B ZA938116 B ZA 938116B ZA 938116 A ZA938116 A ZA 938116A ZA 938116 A ZA938116 A ZA 938116A ZA 938116 B ZA938116 B ZA 938116B
- Authority
- ZA
- South Africa
- Prior art keywords
- ketorolac
- transdermal delivery
- transdermal
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96880092A | 1992-10-30 | 1992-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA938116B true ZA938116B (en) | 1995-05-02 |
Family
ID=25514795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA938116A ZA938116B (en) | 1992-10-30 | 1993-10-29 | Transdermal delivery of ketorolac |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU5450494A (en) |
IL (1) | IL107448A0 (en) |
MX (1) | MX9306791A (en) |
WO (1) | WO1994009777A1 (en) |
ZA (1) | ZA938116B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2414675B (en) * | 2004-06-05 | 2006-09-06 | Dewan Fazlul Hoque Chowdhury | Transdermal drug delivery device |
DE102007034976A1 (en) | 2007-07-26 | 2009-01-29 | Bayer Healthcare Ag | Medicinal products for transdermal use in animals |
GB2467377A (en) | 2009-02-02 | 2010-08-04 | Nemaura Pharma Ltd | Transdermal patch with extensor means actuated to expel drug towards the skin of a patient |
EP3383374A4 (en) * | 2015-11-30 | 2019-07-24 | Elliptical Therapeutics, LLC | Systems and methods for transdermal drug delivery |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
JPH07112984B2 (en) * | 1989-04-28 | 1995-12-06 | 久光製薬株式会社 | Foam aerosol formulation |
US5091182A (en) * | 1990-07-23 | 1992-02-25 | Syntex (U.S.A.) Inc. | Dispensing units for ketorolac topical gel formlations |
JP3243564B2 (en) * | 1990-08-20 | 2002-01-07 | リードケミカル株式会社 | External patch |
JP3541849B2 (en) * | 1991-04-19 | 2004-07-14 | 久光製薬株式会社 | Anti-inflammatory analgesic patch |
-
1993
- 1993-10-29 ZA ZA938116A patent/ZA938116B/en unknown
- 1993-10-29 AU AU54504/94A patent/AU5450494A/en not_active Abandoned
- 1993-10-29 WO PCT/US1993/010219 patent/WO1994009777A1/en active Application Filing
- 1993-10-29 IL IL107448A patent/IL107448A0/en unknown
- 1993-10-29 MX MX9306791A patent/MX9306791A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL107448A0 (en) | 1994-01-25 |
MX9306791A (en) | 1995-01-31 |
WO1994009777A1 (en) | 1994-05-11 |
AU5450494A (en) | 1994-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0800364A4 (en) | Transdermal administration of apomorphine | |
GB9203790D0 (en) | Therapeutic agents | |
ZA939317B (en) | Medicament | |
GB9208463D0 (en) | Therapeutic agents | |
ZA938116B (en) | Transdermal delivery of ketorolac | |
ZA932553B (en) | New use of B-carbolines | |
AU5596394A (en) | Transdermal delivery of ketorolac | |
GB9208116D0 (en) | Therapeutic agents | |
GB9200781D0 (en) | Therapeutic agents | |
GB9226056D0 (en) | Therapeutic use | |
GB9226047D0 (en) | Therapeutic use | |
GB9220714D0 (en) | Therapeutic use | |
GB9214591D0 (en) | Therapeutic composition | |
GB9222633D0 (en) | Therapeutic agetns | |
GB9226728D0 (en) | Therapeutic combination | |
GB9202205D0 (en) | Transdermal delivery device | |
GB9202190D0 (en) | Transdermal delivery device | |
GB9214905D0 (en) | Medicament | |
GB9204767D0 (en) | Medicament | |
GB9202990D0 (en) | Therapeutic agents | |
GB9201104D0 (en) | Therapeutic agents | |
GB9201119D0 (en) | Therapeutic agents | |
GB9203997D0 (en) | Therapeutic agents | |
GB9200662D0 (en) | Therapeutic agents | |
GB9204119D0 (en) | Therapeutic agents |